Data from Basic Health Research shows the prevalence of heart failure in Indonesia is between 0.1% to 0.3% of the entire Indonesian population. This number is predicted to increase from year to year. Heart failure is a complex syndrome that can cause abnormalities in the structure and function of the heart. Based on the ejection fraction values, there are three types of heart failure, namely HFrEF (EF: < 40%), HFmrEF (EF: 40-49%), and HFpEF (EF: ≥ 50%). Considering that the type of heart failure requiring treatment according to ESC guidelines is only HFrEF, however, this study would also evaluate the effect of physician prescribing patterns on the morbidity of HFmrEF. The recommendations from ESC guidelines to the treatment of HFrEF that ca...
Aims In symptomatic patients with heart failure and reduced ejection fraction (HFrEF), recent intern...
Despite tremendous breakthroughs in drug-based and device-based therapy, heart failure continues to ...
AIMS: In symptomatic patients with heart failure and reduced ejection fraction (HFrEF), recent inter...
Data from Basic Health Research shows the prevalence of heart failure in Indonesia is between 0.1% t...
Data from Basic Health Research shows the prevalence of heart failure in Indonesia is between 0.1% t...
Heart failure remains a global burden despite important progress that has been made in the managemen...
Background Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs)...
International audienceAims: In symptomatic patients with heart failure and reduced ejection fraction...
Background: Heart failure is a clinical syndrome occurring from the heart’s inability to effectively...
AIMS: To evaluate the impact of physicians' adherence to guideline-recommended medications for heart...
Introduction Heart failure (HF) is a chronic progressive illness caused by inability of the heart to...
Heart failure (HF) is still characterized by high mortality rates, despite the progress achieved in ...
Aims In symptomatic patients with heart failure and reduced ejection fraction (HFrEF), recent intern...
Despite tremendous breakthroughs in drug-based and device-based therapy, heart failure continues to ...
AIMS: In symptomatic patients with heart failure and reduced ejection fraction (HFrEF), recent inter...
Data from Basic Health Research shows the prevalence of heart failure in Indonesia is between 0.1% t...
Data from Basic Health Research shows the prevalence of heart failure in Indonesia is between 0.1% t...
Heart failure remains a global burden despite important progress that has been made in the managemen...
Background Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs)...
International audienceAims: In symptomatic patients with heart failure and reduced ejection fraction...
Background: Heart failure is a clinical syndrome occurring from the heart’s inability to effectively...
AIMS: To evaluate the impact of physicians' adherence to guideline-recommended medications for heart...
Introduction Heart failure (HF) is a chronic progressive illness caused by inability of the heart to...
Heart failure (HF) is still characterized by high mortality rates, despite the progress achieved in ...
Aims In symptomatic patients with heart failure and reduced ejection fraction (HFrEF), recent intern...
Despite tremendous breakthroughs in drug-based and device-based therapy, heart failure continues to ...
AIMS: In symptomatic patients with heart failure and reduced ejection fraction (HFrEF), recent inter...